23 The main focus of this approach is to talk with patients who are initiating therapy about expected AEs, nonpharmacologic counseling, presence of any other GI conditions, and individualizing dose titrations
Use of GLP-1 drugs for weight loss is common (as much as 12% of the population), but long-term adherence to the medications has been reported to be poor
Generally speaking, the injectable forms provide better weight loss, however, newer higher dose oral GLP-1s are making significant headway
Whether you need personalized guidance or a prescription routine to tackle symptomsincluding vaginal dryness and irritation, brain fog, hot flashes, sleep trouble, mood swings, and weight gainweve got you covered
There are a lot of challenges in the space and it's a fairly new field." Chronic conditions are the next chapter for digital health Weight loss telehealth platform Calibrate launched in 2020, before new drugs like Wegovy entered the market
Spencer Nadolsky, told me last year that he was more open to compounded medications than he used to be (when they were legal), but preferred the name-brand options: Im still cautious about it because I think it would be really nice to know more about it if its been studied more
